Drug intelligence / Profile preview

nigella sativa seed extract

Development stage
Unknown
Lead developer
Universitas Indonesia
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Nigella sativa seed extract is a botanical product derived from the seeds of the *Nigella sativa* plant, commonly known as black cumin or black seed. It has been investigated by researchers at Indonesia University (Universitas Indonesia) as a potential adjuvant therapy for hypertension, particularly in the elderly. The extract is thought to exert antihypertensive effects through multiple mechanisms, including diuretic activity, inhibition of sympathetic nervous system overactivity, and enhancement of nitric oxide production, which promotes vasodilation. In a randomized, double-blind, placebo-controlled trial conducted at Cipto Mangunkusumo National Hospital in Jakarta, the extract was administered at a dose of 300 mg twice daily. While some studies suggest a modest blood pressure-lowering effect in adults, results in the elderly population have been inconclusive, with some trials showing a trend toward reduction without reaching statistical significance.

Other names
black cumin extractblack seed extractKalonji extract
02

Targets

CaV (Voltage-gated calcium channel protein complex)ADRA1A (α1A)

Beyond the preview

Go deeper on nigella sativa seed extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nigella sativa seed extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call